Neuroimaging as a Marketing Tool
Neuroimaging as a means for validating whether a stimulus such as advertisement, communication, or product evokes a certain mental response such as emotion, preference, or memory, or to predict the consequences of the stimulus on later behavior such as consumption or purchasing.
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8137681 | Polyanionic polymer adjuvants for B saccharide vaccines The present invention relates to the field of vaccines, and in particular vaccines comprising antigens of low isoelectric point at pH 7.0, in particular the capsular polysaccharide or oligosaccharide of H. influenzae B (PRP). Immunogenic compositions and meth... | 03/20/2012 |
| 8007818 | Polyanionic polymer adjuvants for haemophilus influenzae B saccharide vaccines The present invention relates to the field of vaccines, and in particular vaccines comprising antigens of low isoelectric point at pH 7.0, in particular the capsular polysaccharide or oligosaccharide of H. influenzae B (PRP). Immunogenic compositions and meth... | 08/30/2011 |
| 7838014 | Vaccine compositions comprising L2 and/or L3 immunotype lipooligosaccharides from LGTB- The present invention relates to the field of neisserial vaccine compositions, their manufacture, and the use of such compositions in medicine. More particularly it relates to processes of making novel engineered meningococcal strains which are more suitable for the... | 11/23/2010 |
| 7655693 | Compounds The invention provides a compound of formula (I), pharmaceutical compositions thereof, and methods of treatment using the same. ... | 02/02/2010 |
| 7628995 | Outer membrane vesicles and uses thereof The present invention discloses a Gram negative bacterium in which the expression of a protein involved in LPS transport to the outer membrane is functionally downregulated such that the level of LPS in the outer membrane is decreased compared to a wild-type Gram ne... | 12/08/2009 |
| 7324864 | Apparatus and method for measuring forces imparted on valve assemblies of metered dose delivery containers during manufacture thereof An axial force measurement apparatus (40) comprises a head member (42) adapted for receiving force imparted by an external force-applying source, and a transducer (44) such as a load cell for measuring the amount of force applied to the head mem... | 01/29/2008 |
| 7321059 | Compounds for use as surfactants Compounds of formula (I): or salts or solvate thereof, wherein: n and N independently represent an integer 2 to 12; m1 and m2 independently represent an integer 1 t... | 01/22/2008 |
| 7319109 | Farnesoid X receptor agonists The invention relates to a compound of formula (I): wherein all variables are as defined herein and to pharmaceutical compositions, methods of using, and processes for preparing the same. ... | 01/15/2008 |
| 7302948 | Fluid dispensing device A fluid dispensing device comprising a body defining a cavity and a dispensing nozzle. A fluid discharging device is housed in the cavity. The fluid discharging device has a hollow casing defining a reservoir for containing a volume of fluid and a plunger slidingly ... | 12/04/2007 |
| 7277168 | Method and system for real-time fluorescent determination of trace elements A system for real-time fluorescent determination of trace elements comprising transport means for moving a plurality of samples, means for generating a plurality of incident radiation pulses of different wavelength, means for illuminating at least a respective one o... | 10/02/2007 |
| 7258119 | Dispenser A dispensing apparatus for dispensing a unit dose of a pharmaceutical substance, in particular for intranasal administration, is described. The apparatus includes a nozzle unit having a safety cap thereon and an actuating device. The safety cap has legs, which can l... | 08/21/2007 |
| 7217833 | Carboxylic acid compounds for use as surfactants Compounds of formula (I) or a salt or solvate thereof, wherein: x represents 0 or 1; y represents 0 or 1; R1 and R2 independently represent —C1-... | 05/15/2007 |
| 7217409 | Alkanoic acid derivatives A method for treating respiratory disorders comprises administering to a patient a pharmaceutical aerosol formulation comprising: (i) a compound of formula (I) or a salt or solvate thereo... | 05/15/2007 |
| 7195752 | Surfactant compounds and uses thereof A pharmaceutical aerosol formulation that includes a particulate medicament, one or more fluorocarbon or hydrogen-containing fluorocarbon propellants and a compound of the general formula (I) or a salt or solvate... | 03/27/2007 |
| 7157457 | Compounds useful in the treatment of inflammatory diseases There are provided according to the invention, novel compounds of formula (I) wherein R1, R2, R3, R4, R5, R6, X, a, b and Z are as defined in the ... | 01/02/2007 |